NYSE:CVS - CVS Health Stock Price, News, & Analysis

$54.17
-0.42 (-0.77 %)
(As of 06/14/2019 04:00 PM ET)
Today's Range
$54.05
Now: $54.17
$54.68
50-Day Range
$52.37
MA: $53.98
$57.33
52-Week Range
$51.72
Now: $54.17
$82.15
Volume4.68 million shs
Average Volume8.37 million shs
Market Capitalization$70.37 billion
P/E Ratio7.65
Dividend Yield3.66%
Beta0.89
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
CUSIP12665010
Phone401-765-1500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$194.58 billion
Cash Flow$15.8392 per share
Book Value$57.46 per share

Profitability

Net Income$-594,000,000.00

Miscellaneous

Employees295,000
Outstanding Shares1,299,090,000
Market Cap$70.37 billion
Next Earnings Date8/14/2019 (Estimated)
OptionableOptionable

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Wednesday, March 6th. Investors of record on Tuesday, April 23rd will be paid a dividend of $0.50 per share on Friday, May 3rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.69%. The ex-dividend date is Monday, April 22nd. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) posted its quarterly earnings results on Wednesday, May, 1st. The pharmacy operator reported $1.62 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.50 by $0.12. The pharmacy operator had revenue of $61.65 billion for the quarter, compared to analyst estimates of $60.39 billion. CVS Health had a positive return on equity of 16.80% and a negative net margin of 0.08%. CVS Health's quarterly revenue was up 34.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.48 EPS. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its FY19 earnings guidance on Wednesday, May, 1st. The company provided earnings per share guidance of $6.75-6.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.77. CVS Health also updated its FY 2019 guidance to $6.75-6.90 EPS.

What price target have analysts set for CVS?

25 equities research analysts have issued 12 month target prices for CVS Health's shares. Their predictions range from $61.00 to $100.00. On average, they anticipate CVS Health's share price to reach $76.4762 in the next year. This suggests a possible upside of 41.2% from the stock's current price. View Analyst Price Targets for CVS Health.

What is the consensus analysts' recommendation for CVS Health?

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 1 sell rating, 7 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Has CVS Health been receiving favorable news coverage?

Press coverage about CVS stock has been trending somewhat negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CVS Health earned a news impact score of -1.0 on InfoTrie's scale. They also gave media headlines about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for CVS Health.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest during the month of April. As of April 30th, there was short interest totalling 20,238,115 shares, an increase of 28.6% from the April 15th total of 15,738,155 shares. Based on an average daily volume of 12,503,380 shares, the days-to-cover ratio is currently 1.6 days. Approximately 1.6% of the company's shares are short sold. View CVS Health's Current Options Chain.

Who are some of CVS Health's key competitors?

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), NVIDIA (NVDA), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Alibaba Group (BABA), Bank of America (BAC), Intel (INTC), General Electric (GE) and Home Depot (HD).

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 63)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 52)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 63)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 55)
  • Mr. Derica W. Rice, Exec. VP & Pres of CVS Caremark (Age 54)

Who are CVS Health's major shareholders?

CVS Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.12%), Wellington Management Group LLP (2.56%), FMR LLC (2.25%), Northern Trust Corp (1.40%), Geode Capital Management LLC (1.35%) and Dimensional Fund Advisors LP (0.99%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which institutional investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Diamond Hill Capital Management Inc., Skandinaviska Enskilda Banken AB publ , Parnassus Investments CA, Boston Partners, Amundi Pioneer Asset Management Inc., Parametric Portfolio Associates LLC and TD Asset Management Inc.. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

Which institutional investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Vulcan Value Partners LLC, Macquarie Group Ltd., Morgan Stanley, Ellis Investment Partners LLC, Primecap Management Co. CA, Geode Capital Management LLC and The Manufacturers Life Insurance Company . Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $54.17.

How big of a company is CVS Health?

CVS Health has a market capitalization of $70.37 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

What is CVS Health's official website?

The official website for CVS Health is http://www.cvshealth.com/.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (NYSE CVS)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  1,157 (Vote Outperform)
Underperform Votes:  652 (Vote Underperform)
Total Votes:  1,809
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel